Komboglyze Европейский союз - словенский - EMA (European Medicines Agency)

komboglyze

astrazeneca ab  - metformin hidroklorid, saxagliptin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - komboglyze je navedena kot dodatek k prehrane in vadbe za izboljšanje glycaemic nadzor pri odraslih bolnikih, starih 18 let in starejši s sladkorno boleznijo tipa 2 neustrezno nadzorovano na njihovo maksimalno odmerkom metformin sam ali tiste, ki že zdraviti s kombinacijo saxagliptin in metformin kot ločene tablet. komboglyze je prikazano tudi v kombinaciji z insulin (i. trojna kombinacija terapija), kot dodatek k prehrani in vadbi za izboljšanje glycaemic nadzor pri odraslih bolnikih, starih 18 let in starejših s tipa 2 sladkorna bolezen, ko inzulin in metforminom sam ne zagotavljajo ustrezne glycaemic nadzor.

Glubrava Европейский союз - словенский - EMA (European Medicines Agency)

glubrava

takeda pharma a/s - metformin hidroklorid, pioglitazone hidroklorid - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - glubrava je naveden kot drugi vrstici zdravljenje tip-2 sladkorne bolezni odraslih bolnikov, zlasti prekomerne bolniki, ki ne morejo doseči zadostno glycaemic nadzor na njihovo maksimalno odmerkom ustni metformin sam. po začetku terapije z pioglitazone, bolnike je treba pregledati in po treh do šestih mesecih, da oceni ustreznost odziva na zdravljenje (e. zmanjšanje hba1c). pri bolnikih, ki ne kažejo ustrezen odgovor, pioglitazone, je treba prekiniti,. v luči možnih tveganj z dolgotrajna terapija, predpisovalce morajo potrditi na kasnejše redne preglede, da je korist pioglitazone je ohranjena.

Eucreas Европейский союз - словенский - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Zomarist Европейский союз - словенский - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Eprocliv 50 mg/1000 mg filmsko obložene tablete Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

eprocliv 50 mg/1000 mg filmsko obložene tablete

metformin; sitagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin

Eprocliv 50 mg/1000 mg filmsko obložene tablete Словения - словенский - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

eprocliv 50 mg/1000 mg filmsko obložene tablete

metformin; sitagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin